FdaApplication
ANDA 217042
Identifiers
- fda_app_no: ANDA217042
Properties
| Property | Value |
|---|---|
| applicant_name | MACLEODS PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2026-06-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAPENTINE | RIFAPENTINE | 150MG | TABLET;ORAL |
1 product